NCT00758004
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Clinical trial condition
Hypercholesterolemia
Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.
719 public trials
20 recruiting studies
Hypercholesterolemia trial results
NCT00777517
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site Singapore
NCT02772640
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Behavior, +16 more
- Locations
-
- Cardiology Department, Dr. A. Jurasz University Hospital Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Completed
Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
NCT01107743
- Conditions
- Angina Pectoris, Cardiovascular Diseases, Chest Pain, +21 more
- Locations
-
Not specified
NCT01190007
- Conditions
- Angina Pectoris, Cardiovascular Diseases, Chest Pain, +14 more
- Locations
-
- Healthcare Corporation MEDOC Medical Dock&Clinic Nagoya, Aichi-ken, Japan
- Beppu Medical Clinic Dazaifu, Fukuoka, Japan
- Morizono medical clinic Kitakyushu, Fukuoka, Japan
- Gakkentoshi Clinic Nishiku, Fukuoka, Japan
NCT00407537
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +6 more
- Locations
-
- Pfizer Investigational Site Desamparados, Provincia de San José, Costa Rica
- Pfizer Investigational Site Heredia, Costa Rica
- Pfizer Investigational Site San José, Costa Rica
- Pfizer Investigational Site Breznički Hum, Croatia
NCT02374047
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Spaulding Clinical Research West Bend, Wisconsin, United States
NCT00530946
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +6 more
- Locations
-
- Pfizer Investigational Site Fukuoka, Japan
- Pfizer Investigational Site Kitakyushu-shi, Fukuoka, Japan
- Pfizer Investigational Site Kurume-shi, Fukuoka, Japan
- Pfizer Investigational Site Maebaru-shi, Fukuoka, Japan
NCT02612090
- Conditions
- Dyslipidemias, Glycemic Response, Hypercholesterolemia, +4 more
- Locations
-
- Clinical Nutrition Research Center Chicago, Illinois, United States
NCT03593785
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Research Site Glendale, California, United States